Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Fuente:
FierceBiotech
The FDA specifically took issue with the trial's control arm, which incorporated a "licensed standard-dose seasonal influenza vaccine," per Moderna's press release.